LENZ Therapeutics, Inc. insider trading
LENZ$3.58-0.21 (-5.54%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-92.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Unlock quarterly net flowKey players
- JWJames W. McCollum2.0086%
- EBEvert B. Schimmelpennink0.246%
- DRDaniel R. Chevallard0.041%
- JPJeffrey P. George0.0178%
- SOShawn Olsson0.0151%
- VVVersant Ventures VI GP, L.P.Not reported
- VVVersant Venture Capital VI, L.P.Not reported
- VVVersant Ventures VII GP, L.P.Not reported
- VVVersant Ventures VII GP-GP, LLCNot reported
- VVVersant Vantage II GP-GP, LLCNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| LENZ | Jeffrey P. George | Open market purchase$49.9K | Not reported | $8.92 | $49.9K | Mar 27, 2026 | Mar 30, 2026 |
| LENZ | Evert B. Schimmelpennink | Open market purchase$251K | +57.1% | $8.95 | $251K | Mar 27, 2026 | Mar 30, 2026 |
| LENZ | Daniel R. Chevallard | Open market purchase$64.3K | +139.3% | $8.57 | $64.3K | Mar 27, 2026 | Mar 30, 2026 |
| LENZ | James W. McCollum | Open market purchase$239K | +1.7% | $22.79 | $239K | Nov 7, 2025 | Nov 10, 2025 |
| LENZ | Daniel R. Chevallard | Open market purchase$49.6K | +67.9% | $22.76 | $49.6K | Nov 7, 2025 | Nov 7, 2025 |
| LENZ | Daniel R. Chevallard | Open market purchase$454 | +0.6% | $22.71 | $454 | Nov 7, 2025 | Nov 7, 2025 |